Patients chronically infected with HCV-1 ( n = 235 ) and a screening viremia < or = 600,000 IU/mL ( real-time PCR ) were treated with peginterferon alfa-2b 1.5 microg/kg subcutaneously once weekly plus ribavirin 800-1400 mg/day based on body weight for 24 weeks .
